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Abstract: 
 
Purpose: Characterization of the downfield spectrum at 5-10ppm, which is less well 
characterized than upfield, in human brain at a high magnetic field of 7T. Knowledge of 
relaxation parameters is of interest for spectroscopy as well as chemical exchange dependent 
saturation transfer experiments. 
Methods: This work includes water-suppressed echo time and inversion recovery series in 
healthy volunteers to investigate, respectively, T2 and T1 values of peaks in grey matter at 7T. 
The spectra were fitted in a 2D fashion to a heuristic model of a series of Voigt lines, and the 
relaxation times were obtained for twelve peaks of interest.  
Results: Mean T2’s averaged over the volunteers ranged from 24-158ms, while mean T1’s 
ranged from 0.22-2.40s. Spectra of specific inversion and echo times reveal superposition of the 
amide peaks of NAA with short T2 and an inhomogeneously broadened component with longer 
T2. 
Conclusions: T2 values were shorter than expected for most peaks, while T1 values had a very 
large range; shorter relaxation times for some peaks suggests the presence of macromolecules. 
Most of the larger peaks seem to be composed of overlapping components, as the Gaussian 
widths in the Voigt lineshape descriptions are larger than expected based on field 
inhomogeneities.  
 
Key words: proton MR spectroscopy; 7T; human brain; metabolites; T1 relaxation time; T2 
relaxation time  
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Introduction: 
Magnetic resonance spectroscopy (MRS) is a noninvasive tool to measure changes in 
metabolite concentrations that are often not reflected by abnormalities in MR images, or in other 
non-invasive imaging modalities. Thus far, the characterization and quantification of the upfield 
side of the 1H MR spectrum, to the right of the water peak, has been the focus at lower field 
strengths as well as higher field strengths, up to 9.4 T in human brain in vivo measurements (1-
3). However, the downfield side of the spectrum, to the left of the water peak, is less well-
characterized. While there are technical challenges associated with measuring downfield 
spectra, including lower signal to noise ratio and several exchanging peaks, it would be 
beneficial to determine both the identity of the visible peaks as well as their characteristics such 
as concentration, T1, and T2.  
Downfield metabolites such as adenosine triphosphate (ATP), homocarnosine, glutathione, 
phenylalanine, and glutamine (4) may be of interest in metabolism and disease. For example, 
ATP is present upfield, but close to th  water resonance, complicating quantification. Other 
interests in downfield spectra involve metabolites which exchange with water and can be 
measured using chemical exchange dependent saturation transfer (CEST) experiments; 
spectroscopy experiments on exchanging species may aid in improving CEST quantification.  
Downfield MR spectroscopy has been performed in animals at up to 11.74 T, with tentative 
assignments of peaks including NAA at 7.8 ppm, NAD+ in the 8.7 – 9.5 ppm region, and 
proteins at 8.3 ppm, and with a focus on exchanging peaks (5-7). In humans, experiments have 
been run downfield at field strengths up to 7 T, investigating various resonances including NAA 
and several other peaks in the range from 5.9 ppm to 8.6 ppm (8-12). While some peaks are 
assigned to various metabolites based on expected resonances as well as water exchange 
(WEX) filter experiments (13), others remain unassigned and may be composed of multiple 
overlapping resonances. T1 and exchange measurements have only investigated six of the 
visible peaks between 6.5 ppm and 8.6 ppm (8), and there is only a single report on T2’s of 
downfield peaks from a study at 1.5T (11) and preliminary accounts of T2 attenuation at 1.5 and 
3T (10), as well as 7T (9). These parameters may aid in designing further experiments to 
separate out the various potentially overlapping peaks of different metabolites downfield, as well 
as to determine the presence of any macromolecular baseline. 
Performing MRS measurements at higher field strengths improves SNR and spectral resolution. 
However, several disadvantages remain and need to be accounted for, including a shorter T2 of 
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the metabolites and higher radiofrequency power deposition. A shorter T2 leads to line 
broadening as well as a smaller signal at longer echo times; therefore, a sequence with a short 
echo time is necessary at higher fields, particularly if one wishes to evaluate the T2 of the 
metabolites.  
In the current study, a STimulated Echo Acquision Mode (STEAM) sequence was used with a 
short echo time and a long repetition time to minimize the specific absorption rate, or amount of 
energy deposited. The focus of these experiments was to obtain T1 and T2 estimates downfield 
in grey matter (GM) in vivo in human subjects at 7 T and thereby to distinguish between small 
metabolite resonances and contributions from macromolecules. Increased knowledge about the 
downfield peaks can aid in the development of a model for better quantification in the future, 
and enable downfield measurements to be more easily used to determine changes in the brain 
due to metabolism or disease.  
Methods: 
Subjects 
For the echo-time series, twelve healthy adults aged 21-49 years (mean 28 years) with no 
history of neurologic or psychiatric disorders were recruited, and for the inversion recovery 
series, ten healthy adults aged 21-49 years (mean 27 years) were recruited. Written, informed 
consent was obtained according to the local institutional ethics review board. Spectra from two 
subjects for the echo-time series were not included in the analysis due to excessive line 
broadening, most likely due to motion over the duration of the scan sessions. 
MRS Data Acquisition 
Subjects were scanned on a 7 T Philips Achieva MR system with a quadrature transmit/receive 
visual cortex surface coil (RAPID Biomedical, Rimpar, Germany). Sagittal, axial, and coronal T2-
weighted images were used for prescription of a mostly grey matter voxel of size 4.0 x 2.0 x 
2.0 cm3 in the visual cortex at the back of the head, avoiding major blood vessels. 
Second-order local projection based B0 shimming was applied using a Philips implementation 
(14) of FASTmap, FASTERmap, and FASTESTmap (15-18). Water suppression was achieved 
using an eight-pulse variable pulse power and optimized relaxation delays (VAPOR) (19) 
scheme (sinc-Gauss pulses, bandwidth 250 Hz) prior to the localization sequence. The VAPOR 
delays were 150, 100, 122, 105, 102, 61, and 67 ms for the seven pre-localization pulses. The Ev
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acquisition bandwidth was 4000 Hz, the number of data points acquired 2048, the RF pulse 
centre frequency was set at 7.5 ppm, and a 16-step phase cycling scheme was used. 
The TE series was acquired using STEAM with a mixing time TM of 26.0 ms and a repetition 
time (TR) of 4000 ms. A series of echo times: 13.0, 23.4, 34.7, 46.8, 60.0 ms was acquired in 
each of the subjects, 256 averages per TE were collected in blocks of 64 averages each, and 4 
unsuppressed water spectra were also acquired per block. 
The IR series was acquired also using STEAM with a TM of 26.0 ms, a TE of 13.0 ms, and a TR 
of 7000 ms; the inversion times were 45, 150, 290, 580, 800, 1200, 2500, 4000, and 6000 ms. 
The nonselective trapezoidal adiabatic inversion pulse was interleaved with the VAPOR water 
suppression pulses as in Ref. (20), and the inversion times were calculated such that there was 
no overlap between the inversion pulse and any VAPOR pulse. At each inversion time, 64 
averages were acquired, and 4 unsuppressed water spectra were also acquired.  
MRS Data Analysis 
All data were saved in the Philips raw data format, and exported and reconstructed in Matlab 
(MATLAB and Statistics Toolbox Release 2014b, The MathWorks, Inc., Natick, Massachusetts, 
United States). Oversampling was removed, a DC offset correction was applied, and the data 
were averaged, all using the ReconFrame framework (GyroTools LLC, Zurich, Switzerland). 
Following that, further processing in Matlab was done separately from ReconFrame, starting 
with 0th order phase adjustment and then frequency alignment of the various data sets for each 
set of experiments using cross-correlation. For the TE series, the four sets of 64 averages for 
each echo time were then averaged together. For both TE and IR series, the data were then 
eddy current corrected using the corresponding data from non-water-suppressed scans (21). 
Data sets were aligned between volunteers, and were then also averaged to create a model 
spectrum with higher signal to noise ratio (SNR). The same processing was performed on the 
unsuppressed water data as for the water-suppressed spectra, including self-eddy current 
correction.  
The overall averaged data sets from both series were used to develop a model in FiTAID (22); 
using the averaged data sets, prior knowledge was defined with twelve peaks in the 5 to 9 ppm 
region (see Figure 1). The peaks from N-acetylaspartate (NAA) at 7.82 ppm and α-glucose (Glc) 
at 5.22 ppm (4) were defined as binary patterns, as modeled in VESPA (23) based on the 
known spin systems. Homocarnosine (hCs) was also defined at two locations, 7.05 and Ev
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8.02 ppm as suggested by literature (24). Several other lines were used in the model, including 
one for an artifact at approximately 5.6 ppm which appeared in three of the TE series subjects, 
as well as a line to fit the residual water, a very broad line centered at the water frequency for 
any baseline effects, and another numeric pattern to account for the upfield spectra.  
Subsequently, the individual volunteers’ IR and TE data sets were fitted simultaneously within 
each time series using Voigt lineshapes, where the simultaneous fit mode helped to overcome 
the very low SNR for some of the peaks in individual spectra, particularly at long TE or the 
inversion null. Fitted parameters included peak area, offset, phase, Lorentz width (=1/(πT2)), 
Gaussian width, and relaxation constant R1 (=1/T1), with the FiTAID model assuming full 180° 
inversion for the IR series. The NAA doublet peaks were linked such that their offset, area, 
Lorentz width, Gaussian width, and relaxivity R1 were the same. The two homocarnosine peaks 
were also linked such that their areas, Lorentz width, and R1 were identical, and the difference 
in their offset was fixed. Phase for the downfield spectrum was fixed and not varied between 
peaks; relative offsets between peaks were also not allowed to change from what had been 
found for the averaged data. Similarly for the Gauss width components; they remained at what 
was found for the averaged data, except that an additional Gauss broadening term was allowed 
to vary and adapt for different shim settings in the different data sets. In addition, for the TE 
series, R1 was fixed based on the averaged data while the Lorentz width was fitted. Inversely, 
for the IR series, the Lorentz width was fixed based on the fit of the averaged data  and R1 was 
fitted. Fitting errors for all estimated parameters were determined as Cramer-Rao Lower Bounds 
(CRLB) (25). 
Unsuppressed water data were also fitted in FiTAID, using a two-line model to account for the 
presence of cerebrospinal fluid (CSF). Metabolite concentrations were calculated using the 
relaxation-corrected water areas and a grey matter water concentration of 0.83 g/ml (26). 
Not all of the fits were considered reliable; those with areas varying further than two standard 
deviations from the median area of the corresponding peak over all the individuals or those 
which hit the upper or lower limit of Lorentz width or R1, for the T2 or T1 series, respectively, 
were removed. In addition, in some cases, the Fisher information matrix became singular and 
non-invertible, and singular value decomposition was used to calculate a pseudo-inverse of the 
matrix. The reason for the singularity was little/no influence of a parameter on the model (e.g. in 
some cases the Lorentz width was not relevant since the amplitude of the peak was extremely Ev
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small); parameters with infinite CRLB values were therefore also excluded from the final 
calculations.  
For the calculation of the mean T2 values and concentrations from the TE series, the α-glucose 
peak had two data sets removed; for homocarnosine, three were removed; the 5.73 ppm peak 
was poorly fitted and had eight data sets removed, while the 5.97 ppm peak had three removed 
and the 6.11 ppm had nine removed due to both infinite CRLB and in some cases hitting the 
limit for the Lorentz width. The 6.81 ppm and 8.08 ppm peaks had only one removed each, and 
the 7.06 ppm, 7.29 ppm, 8.0 ppm, and NAA peaks had none removed. For the calculation of the 
mean T1 values and concentrations from the IR series, α-glucose and the 5.73 ppm peak had 
two data sets removed; homocarnosine, the 5.97 ppm, and the 6.81 ppm peak each had one 
data set removed, and the 6.11 ppm peak had five removed; the remaining peaks had none 
removed. Mean and standard deviations were calculated for the remaining data sets. 
Results: 
The average TE and IR series spectra used to create the model in FiTAID are shown in Figure 
2. The appropriateness of the heuristic signal model can be judged from Figure 1, where the 
individual components are illustrated for the averaged short TE spectrum without inversion. 
Substantial inhomogeneous broadening (i.e. considerably larger Gauss component in the 
individual Voigt lines than found for the narrowest peaks of NAA and Glc) was found for peaks b 
to e with additional Gaussian broadening of 17 to 40 Hz (and the very broad baseline peak a).  
Relaxation times and concentrations for all components were determined from the individual 
data sets. Mean T2 estimates for metabolites were determined to be in the range of 24.3 to 
158 ms, while mean T1
 values were in the range of 0.17 to 2.40 s. The mean water T2 for the 
GM component was calculated to be 39.2 ± 3.1 ms (SD), while the mean water T1 for GM was 
found to be 1.66 ± 0.09 s. The estimates for relaxation parameters and metabolite 
concentrations are shown in Tables 1 and 2, as mean and SD over the individuals, and the 
mean of the individual fitting uncertainties is also included. In addition, relaxation parameters 
and concentrations are given for the average spectra, useful in particular as comparison for the 
smaller peaks. Most of the peaks are unassigned and are therefore identified according to a 
label as shown in Figure 1. Examples of an individual fit with the spectrum and residuals are 
shown in Figure 3. Plots indicating the entire range of results for T1 and T2 values, including the 
outliers removed before determining mean values, are given in Figure 4. Ev
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Discussion: 
The results from the current study provide T1 and T2 values at 7 T, as well as concentration 
estimates for twelve peaks of interest downfield from a mostly grey matter voxel. The relaxation 
parameters discussed here provide information on more peaks than the six previously shown 
downfield in human brain at 3 T (8) and relaxation differences point at the presence of 
macromolecular components. 
As can be seen from the CRLB and the standard deviations over the cohorts in Tables 1 and 2, 
the results for several peaks were very consistent, including the NAA peaks and several of the 
larger downfield peaks. Other peaks were more difficult to fit, such as the α-glucose, suffering 
from additional baseline effects due to its proximity to the water peak, and several of the smaller 
peaks, which were more difficult to see in the individual spectra compared to the averaged 
spectra. These gave a wider range of results for T1, T2, and concentrations. 
Metabolite concentrations 
The metabolite concentrations found for the known downfield peaks for the most part match 
very well to the literature values (1,3,4). The narrow NAA amide doublet corresponds to a 
concentration of 10.5 mM from the T2 measurements and a concentration of 9.9 mM from the T1 
measurements, agreeing with each other and literature values of an average of 10.3 mM (4). 
Homocarnosine, which was included in the model as two peaks based on prior knowledge as it 
overlaps with other peaks, yielded a concentration of 0.27 mM from the T1 measurements and 
0.39 mM from the T2 measurements. This is close to the literature values of 0.23 mM (4) and 
0.3-0.4 mM (24,27). The literature suggests a concentration of 0.5 mM for α-glucose (12), which 
is comparable to the concentrations of 0.77 mM and 0.44 mM obtained in the current study, 
although it should be noted that the α-glucose peak may be somewhat affected by the transition 
band of the 250 Hz-bandwidth water suppression pulses. Other peak concentrations are more 
difficult to discuss, as some of them are likely to be composed of various metabolites and 
remain unassigned, as discussed later. 
Water T1 and T2 
The mean water T1 and T2 were found to be 1.66 ± 0.09 s and 39.2 ± 3.1 ms, respectively. The 
T1 is lower than the recently found 2.0s for grey matter at 7 T (2); however, in that case the CSF 
was not accounted for when fitting the grey matter voxel, and may have led to a larger T1 than 
measured here, although imaging studies suggest a range of T1 values somewhere in between 
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the two results (28). The T2 is in the expected range for grey matter at higher fields, although 
still slightly below the average literature values found for 7 T which are mostly above 41 ms 
(1,29).  
Metabolite relaxation values 
Compared to the 3 Tesla T1 values found by MacMillan et al (8), the values found at 7 T are, for 
the most part, substantially higher. However, the 3 T results were found through modeling of 
exchange experiments (selective inversion of water peak), in contrast to the non-selective 
inversion recovery experiments run at 7 T, and cannot be directly compared. Some of the peaks 
have fairly large standard deviations, either because they arise from small features that are 
difficult to fit in individual spectra or because their T1 is so short that the choice of inversion 
times was not ideal to determine them accurately.  
There are few publications discussing downfield T2 values; one set of experiments done at 1.5 
T, however, does list a T2 value for NAA of 17 ms and for the 7.3 ppm peak of 52 ms (11). 
These values differ somewhat from the values found at 7 T, but are of a similar order of 
magnitude; furthermore, their work also indicates a second component of the NAA peak at 8.0 
ppm, similar to the findings of an extra component at 7.87 ppm at 7 T. A comparison to upfield 
shows that most of the downfield T2 values found are significantly shorter, at approximately 24-
43 ms, than those found at 7 T for upfield metabolites, which were mostly within a range of 60-
200 ms (1). However, some of the peaks have values in a similar range above 100 ms, such as 
homocarnosine, the 5.97 ppm peak (peak g in Figure 1), and α-glucose, with slightly less 
accurate fits, as mentioned earlier. It should be noted that Marjanska et al. (1) found different T2 
values for different areas in the brain; direct comparisons therefore may depend on which area 
of the brain is being investigated. The longer T2 for the α-Glc peak is in line with expectations 
based on work by Gruetter et al (12) at 4 T. 
For the NAA amide peak, the mean T1 was found to be 1.84 s at 7 T, while at 3 T  the median T1 
was estimated from the inversion transfer to be 0.53 s, which is a larger difference than that 
typically seen between 3 T and 7 T for upfield peaks. The difference may partly be due to the 
different experiment types and partly due to the fact that at 3 T, the broader NAA resonance 
fitted for T1 included the shoulder that was fitted separately at 7 T, with a T1 of 0.85 s. On the 
other hand, the NAA amide N-H peak was found to have a very short T2 of 28.0 ± 2.4 ms, with 
consistent fits across all subjects, which is in strong contrast to the upfield spectrum, where the 
NAA acetyl group has one of the longer T2 values also at 7 T, for e.g. 132 ms for the methyl 
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peak and 90 ms for the aspartate CH2 group in the occipital lobe (1). Exchange could be 
expected to play a role, leading to an apparently shorter T2; however, MacMillan et al. (8) found 
that the NAA peak has a very low exchange rate of 0.5 Hz, which would not contribute much to 
the apparent T2. Alternatively, the apparent T2 of the amide peak may well be dominated by 
scalar relaxation mediated by J-coupling (expected to be on the order of 60 Hz) to the fast 
relaxing nitrogen-14 in NAA. To pinpoint this effect is, however, beyond the scope of this work, 
but may be of considerable interest for in vivo amide peaks in general.  
A peak at 7.87 ppm (peak b in Figure 1) contributes a broad shoulder to the larger NAA peak; it 
has a shorter T1 than many of the other peaks but a longer T2 than the NAA peak itself. It can be 
seen in Figure 2 that it recovers faster in the IR series than NAA, with a broader peak visible at 
TI = 1.20 s. To better visualize that there is indeed an additional component at 7.87 ppm, a 
scaled version of these traces is given in Figure 5, where the 7.87 ppm peak appears clearly 
shifted and broader than the NAA peak that dominates and lines up across the other plotted 
traces. Given that this broad peak at 7.87 ppm and several other peaks were described by Voigt 
lines with Gaussian components that are much larger than the contribution from local B0-
inhomogeneity indicates per se that these peaks consist of multiple contributing components 
and the determined relaxation times can only give a rough estimate for the main contributors at 
these chemical shift positions. It also explains why a broad component, like the one at 7.87 
ppm, can be associated with a longer T2 than the narrower NAA amide peak, which even 
consists of a J-coupling doublet. 
Knowledge of the relaxation values is also of interest for determining the presence of 
macromolecules. The peak at 6.81 ppm (peak e) has a very short T1 of 0.47 s compared to 
many of the other well-fitted peaks (not including the 6.11 ppm (peak f) and 5.73 ppm (peak h) 
peaks, which were small and more difficult to fit accurately). The shorter T1 compared to upfield 
T1’s and to other downfield peaks, in addition to a short T2 of 24.4 ms indicates the likely 
presence of a macromolecular contribution to the peak. The other two peaks at 7.06 and 
7.29 ppm (peaks d and c) also have short T1’s of 0.74 s and 0.70 s respectively, higher than at 
3 T but only slightly higher than the macromolecular T1 of 0.43 s found upfield at 7 T (2), and 
therefore may also contain macromolecular components. The relatively short T2 values of 
35.9 ms and 30.4 ms for the 7.06 ppm and 7.29 ppm peaks, respectively, are in line with the 
potential presence of macromolecules.  
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Comparing T1 values between field strengths is more difficult for the remaining peaks, as the 
area between 8.1-8.5 ppm is strongly affected by exchange (amides), which was minimized in 
the 3 T experiments without water pre-saturation, and the 3 T experiments did not investigate 
peaks as close to the water peak as those at 7 T. 
Peak assignments 
Several peaks such as those from NAA and α-glucose have been unambiguously labeled in 
previous experiments (30); however, many of the peaks investigated in the current study remain 
unlabeled. Tentative peak assignments have been given for downfield peaks previously by 
Henning et al. (9); these labels were based on expected metabolite resonances found in the 
literature. Further labeling or confirmation of peaks is not yet possible with the results obtained 
in this study; however, some suggestions can be made and others ruled out. NAA and α-
glucose remain well-known as downfield peaks at 7.82 ppm and 5.22 ppm (4). Homocarnosine 
was found at both 7.05 ppm and at 8.02 ppm, corresponding to what had been obtained in Ref. 
(24) after vigabatrin treatment (7.05 and 8.02 ppm). The peak at 5.73 ppm may be labeled as 
urea, based on a recent publication (31) and a measured concentration of 2.6 mmol/kg urea in 
human brain extracts (32).  
The peaks at 8.1-8.5 ppm (peak a) are partly due to amide protons which exchange with water 
and have been shown in WEX experiments (13); in the current case, water is suppressed, 
leading to smaller or nonexistent peaks. These peaks may thus arise partially from amide 
protons of peptides/proteins (13) but also from various other metabolites such as glutathione or 
homocarnosine. Two peaks from ATP are expected in this ppm range (8.2 and 8.5 ppm), arising 
from the adenosine moiety. However, if fully visible and present at a level of ~3 mM (4), they 
should actually be considerably more prominent than what is observed in our spectra. These 
protons are not expected to exchange directly with water; any decrease in signal may be due to 
a nuclear Overhauser effect as reported for the aromatic signals from proteins (33) or T2 
shortening because of the specific compartmentation or chemical reactions ATP is involved in. 
To arrive at the low spectral intensities seen in our spectra, T2’s would have to be considerably 
shorter than what was measured for peak a. The same holds for the potential ATP resonance at 
6.12 ppm. It is too small if ATP were fully visible and too narrow to represent T2-shortening and 
signal loss. 
Amine groups also resonate downfield from water. Candidate peaks include ATP at 6.76 ppm, 
creatine at 6.65 ppm, glutamine at 6.82 and 7.53 ppm, homocarnosine at 6.40 ppm, and 
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phosphocreatine at 6.58 and 7.30 ppm. However, as amines tend to exchange rapidly with 
water (34-36), these resonances and any amines from other metabolites such as glutamate and 
GABA are not expected to be visible in these water-suppressed experiments. Similarly, the 
amide peaks of glutathione identified at 8.27 and 8.48 ppm by Grande et al. (37) in cell 
suspensions are expected to be strongly attenuated due to exchange. (These assignments 
contrast with Ref. (4), where the glutathione peaks were assigned to 7.15 and 8.18 ppm, but 
Grande’s assignments are more in line with earlier high resolution work (38)). MacMillan et al.’s 
experiments at 3 T show low exchange rates for the 7.06 and 7.29 ppm peaks (peaks d and c, 
respectively), which may indicate either a small component which exchanges or only slowly 
exchanging species which may still be visible. 
Other resonances expected or previously reported to be visible in the downfield spectrum 
include histidine, tryptophan, tyrosine, and phenylalanine, with all of them present at a low 
concentration only (<0.1 mmol/kgww) but the latter four with 4-5 protons potentially cumulating to  
a small detectable signal. Simulations (not shown) were performed for the 7 T case and indicate 
that these metabolites are too low in concentration to account for substantial parts of the larger 
peaks in the 6.8-7.3 ppm region (peaks c, d, and e).   
Limitations 
An ideal experiment would have no suppression effects on the metabolites from exchange with 
suppressed water; however, the ability to run metabolite cycling experiments to avoid water 
suppression was limited by scanner instabilities. Comparison of water-suppressed and non-
water-suppressed spectra at 3 T (8) suggests that the water suppression sequence has only 
substantial effects for a few of the visible peaks; any peaks affected by very fast exchange 
would not be visible from the metabolite cycling sequence even without water suppression due 
to broadening effects as well as relaxation or exchange after the inversion pulse. Similar effects 
from water suppression would be expected at 7 T, although faster exchanging peaks would be 
expected to be smaller or no longer visible due to the longer VAPOR water suppression 
duration. There could be some effects due to exchange on some of the remaining peaks, 
leading to a shorter T2 than expected; however, the peaks with the highest exchange rates were 
not visible enough for quantification in these experiments. NAA, as mentioned earlier, is likely 
not affected due to a very low exchange rate of 0.5 Hz (8). The presence of exchanging 
peaks/metabolites has been demonstrated in experiments such as WEX (13), where the amide Ev
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protons appeared to be the fastest exchanging, and others had slower exchange rates, and 
therefore were less impacted by water suppression. 
In theory, many resonances should be visible downfield; however, in practice, effects including 
exchange and – as seen from the present results – short T2 are likely to eliminate some of the 
metabolites as contributors to the visible signal. A further limitation is the simplification of the 
spectral fit model, which was developed to characterize visible peaks but not necessarily all 
contributing resonances individually, as many of the peaks are likely due to various overlapping 
resonances. This overlap creates the broader peaks visible in the 6.8-7.3 ppm range; some of 
the metabolites with lower concentrations may be contributing to a larger overall peak.  
Three spectra in the TE series have an artifact, appearing as a dip in the spectrum, at 
approximately 5.6 ppm (denoted by a * in Figure 1); this artifact is less obvious in the averaged 
spectrum than in the individual spectra but was accounted for in the fitting. 
 
Conclusions 
This paper presents first estimates of T1 and T2 at 7 T downfield in grey matter for twelve peaks. 
As downfield spectra have not been well characterized at ultra-high field in humans in vivo, this 
paper presents initial results with the aim to improve the characterization and labeling of the 
peaks. 
T2 values were shorter than expected for most peaks, while T1 values had a very large range, 
suggesting the presence of macromolecules for some of the peaks with shorter T1’s and T2’s, 
such as those at 6.81, 7.06, and 7.29 ppm. The larger peaks were well fitted by the model, while 
the smaller peaks were clearly present but difficult to fit in individual spectra. 
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peak 
MeanT2 ± 
SD (ms) 
CRLB 
(ms) 
T2 from 
average TE 
series (ms) 
Mean T1 ± 
SD (s) CRLB (s) 
T1 from 
average IR 
series (s) 
8.08ppm (a) 38.0 ± 7.1 5.9 37.4 0.22 ± 0.17 0.02 0.36 
hCs 158 ± 87 173 318 2.40 ± 0.52 0.95 2.81 
7.87ppm (b) 40.3 ± 6.3 7.6 44.2 0.84 ± 0.16 0.13 0.85 
NAA 28.0 ± 2.4 1.5 28.7 1.84 ± 0.12 0.07 1.84 
7.29ppm (c) 30.4 ± 4.8 2.8 30.4 0.70 ± 0.04 0.04 0.72 
7.06ppm (d) 35.9 ± 5.4 4.6 35.9 0.74 ± 0.08 0.06 0.75 
6.81ppm (e) 24.4 ± 1.8 2.9 25.5 0.47 ± 0.05 0.05 0.45 
6.11ppm (f) 24.3 ± (N/A) 11.5 74.9 0.17 ± 0.08 0.16 0.23 
5.97ppm (g)  111 ± 80. 138 88 1.91 ± 1.32 1.17 1.38 
5.73ppm (h) 43.6 ± 28.8 28.5 22.4 0.36 ± 0.21 0.12 0.52 
α-glucose 129 ± 84 111 269 1.71 ± 0.50 0.59 1.41 
Water 39.2 ± 3.1 0.007 N/A 1.66 ± 0.09 0.0004 N/A 
 
Table 1. Mean T2 and T1 values for the twelve peaks calculated from individual volunteers’ 
fitted results. Standard deviations (SD) over all the results as well as mean CRLB from the 
results are shown. The T2 and T1 values from the average spectra over the volunteers from 
the TE and IR series, respectively, are also included.  
 
 
 
 
 
 
 
 
 
 
Ev
alu
ati
on
 E
dit
ion
 of
 ac
tiv
eP
DF
 D
oc
Co
nv
ert
er
Vis
it w
ww
.ac
tiv
eP
DF
.co
m 
for
 m
ore
 de
tai
ls.
Page 18 of 48
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
19 
 
Peak 
Mean TE series 
conc.  ± SD (mM) 
CRLB 
(mM) 
Conc. from avg 
TE series (mM) 
Mean IR series 
conc.  ± SD (mM) 
CRLB 
(mM) 
Conc. from avg 
IR series (mM) 
8.08ppm (a) 9.02 ± 1.65 1.09 9.62 8.28 ± 1.85 0.46 9.68 
hCs 0.39 ± 0.11 0.13 0.33 0.27 ± 0.06 0.06 0.53 
7.87ppm (b) 3.02 ± 0.59 0.36 2.93 1.88 ± 0.30 0.26 1.14 
NAA 10.5 ± 1.0 0.78 10.6 9.91 ± 0.98 0.36 9.85 
7.29ppm (c) 4.81 ± 0.69 0.44 5.06 4.44 ± 0.37 0.18 4.58 
7.06ppm (d) 3.35 ± 0.48 0.41 3.58 3.03 ± 0.31 0.18 3.96 
6.81ppm (e) 3.72 ± 0.36 0.49 3.78 2.78 ± 0.21 0.18 3.87 
6.11ppm (f) 0.47 ± (N/A) 0.18 0.11 0.11 ± 0.03 0.05 0.13 
5.97ppm (g)  0.47 ± 0.20  0.15 0.44 0.36 ± 0.05 0.09 0.46 
5.73ppm (h) 0.53 ± 0.43 0.26 0.24 0.81 ± 0.24 0.15 1.26 
α-glucose 0.77 ± 0.30 0.27 0.46 0.44 ± 0.13 0.07 0.54 
 
Table 2. Mean concentrations calculated from the individual results from the 
TE series and the IR series. Standard deviations (SD) over all the results as 
well as mean CRLB from the results are shown. The concentrations from the 
average spectra over the volunteers from the TE and IR series are also 
included. 
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Figure 1.  Averaged spectrum from 10 volunteers at TE=13.0 ms shown in black, overlaid with 
the fit in red, and the individual basis peaks in dark blue; known peaks are shown in colour as 
labelled, with peaks fitted together shown in the same colour. Inset: representative voxel 
location shown in red overlaid on an image of a volunteer’s brain acquired with a surface coil. 
Below the spectrum are the residuals for the fit. NAA, hCs, and Glc were included as known 
peaks, and NAA was fitted as a doublet. Unknown peaks are labelled with letters; j* 
corresponds to an artifact present in three subjects’ data. Other metabolites with non-
exchanging peaks resonating in this downfield region include phenylalanine, tryptophan, 
histidine, and tyrosine; simulations (not shown) indicate that even if summed together, these 
metabolites are too low in concentration to substantially account for the larger peaks in the 6.8-
7.3 ppm region. The peak at 5.73 ppm can potentially be labeled as urea (31). 
 
 
 
Figure 2. Average spectra over all volunteers. No filters applied. a) Average of the echo time 
series spectra for all 10 volunteers; echo times are shown to the left of the spectra. b) Average 
of the inversion recovery series spectra for all 10 volunteers; inversion times are shown to the 
left of the spectra. 
 
 
Figure 3. a) Representative spectra from an individual volunteer for the TE series, b) the 
corresponding fitted spectra for the TE series, and c) the residuals from these fits. d) 
Representative spectra from an individual volunteer for the IR series, e) the corresponding fitted 
spectra for the IR series, and f) the residuals from the pertaining fits. No filters were applied to 
the data. 
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Figure 4. Plots for a) T1 relaxation times and b) T2 relaxation times for the twelve peaks 
downfield, from the fits of each individual volunteer. Black crosses are the included data points, 
red circles indicate data points removed from the calculations, and blue squares indicate the 
mean values. Note that for the T1 relaxation times, three points at T1 = 10 s were removed, two 
from the 6.11 ppm range and one from glucose. 
 
 
Figure 5. Spectra indicating the presence of a component at 7.87 ppm, evidenced by the shift 
when comparing the NAA peak for the average IR series traces at TI = 45 (inverted), 1200, and 
6000 ms. All traces are Gaussian apodized by 6 Hz. The TI = 1200 ms trace is shown in red, 
and is scaled up to match the NAA peaks of the other traces. As all the other peaks align 
between the traces, the shifted peak must therefore be a component other than NAA. 
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Figure 1.  Averaged spectrum from 10 volunteers at TE=13.0 ms shown in black, overlaid with the fit in red, 
and the individual basis peaks in dark blue; known peaks are shown in colour as labelled, with peaks fitted 
together shown in the same colour. Inset: representative voxel location shown in red overlaid on an image 
of a volunteer’s brain acquired with a surface coil. Below the spectrum are the residuals for the fit. NAA, 
hCs, and Glc were included as known peaks, and NAA was fitted as a doublet. Unknown peaks are labelled 
with letters; j* corresponds to an artifact present in three subjects’ data. Other metabolites with non-
exchanging peaks resonating in this downfield region include phenylalanine, tryptophan, histidine, and 
tyrosine; simulations (not shown) indicate that even if summed together, these metabolites are too low in 
concentration to substantially account for the larger peaks in the 6.8-7.3 ppm region. The peak at 5.73 ppm 
can potentially be labeled as urea (31).  
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Figure 2. Average spectra over all volunteers. No filters applied. a) Average of the echo time series spectra 
for all 10 volunteers; echo times are shown to the left of the spectra. b) Average of the inversion recovery 
series spectra for all 10 volunteers; inversion times are shown to the left of the spectra.  
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Figure 3. a) Representative spectra from an individual volunteer for the TE series, b) the corresponding 
fitted spectra for the TE series, and c) the residuals from these fits. d) Representative spectra from an 
individual volunteer for the IR series, e) the corresponding fitted spectra for the IR series, and f) the 
residuals from the pertaining fits. No filters were applied to the data.  
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Figure 4. Plots for a) T1 relaxation times and b) T2 relaxation times for the twelve peaks downfield, from the 
fits of each individual volunteer. Black crosses are the included data points, red circles indicate data points 
removed from the calculations, and blue squares indicate the mean values. Note that for the T1 relaxation 
times, three points at T1 = 10 s were removed, two from the 6.11 ppm range and one from glucose.  
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Figure 5. Spectra indicating the presence of a component at 7.87 ppm, evidenced by the shift when 
comparing the NAA peak for the average IR series traces at TI = 45 (inverted), 1200, and 6000 ms. All 
traces are Gaussian apodized by 6 Hz. The TI = 1200 ms trace is shown in red, and is scaled up to match 
the NAA peaks of the other traces. As all the other peaks align between the traces, the shifted peak must 
therefore be a component other than NAA.  
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